The PML nuclear bodies: actors or extras?
Authors:
- Jacob-S SeelerJSJacob-S Seeler
- Anne DejeanADAnne Dejean
- 1 June 1999
- journal article
- review article
- Published by Elsevier in Current Opinion in Genetics & Development
- Vol. 9 (3) , 362-367
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Complete Remission after Treatment of Acute Promyelocytic Leukemia with Arsenic TrioxideNew England Journal of Medicine, 1998
- Structure, Organization, and Dynamics of Promyelocytic Leukemia Protein Nuclear BodiesThe American Journal of Human Genetics, 1998
- Modulation of Fos-mediated AP-1 transcription by the promyelocytic leukemia proteinOncogene, 1998
- The acute promyelocytic leukaemia specific PML and PLZF proteins localize to adjacent and functionally distinct nuclear bodiesOncogene, 1998
- Distinct interactions of PML-RARα and PLZF-RARα with co-repressors determine differential responses to RA in APLNature Genetics, 1998
- A novel ubiquitin‐specific protease is dynamically associated with the PML nuclear domain and binds to a herpesvirus regulatory proteinThe EMBO Journal, 1997
- Intranuclear Redistribution of SV40T, p53, and PML in a Conditionally SV40T-Immortalized Cell LineExperimental Cell Research, 1996
- PML-containing nuclear bodies: Their spatial distribution in relation to other nuclear componentsJournal of Cellular Biochemistry, 1996
- Targeting of adenovirus E1A and E4-ORF3 proteins to nuclear matrix-associated PML bodies.Journal of Cell Biology, 1995
- Retinoic acid regulates aberrant nuclear localization of PML-RARα in acute promyelocytic leukemia cellsCell, 1994